NFKB1 and hypoparathyroidism-retardation-dysmorphism syndrome: Three immune signaling pathways, including JAK-STAT, NF-κB, and TNF signaling pathways, are conspicuously augmented in the primary tumor sites of HRD cancers, which might imply the origin of the immune signal of HRD tumor cells.